Robeco Institutional Asset Management
MED icon

Robeco Institutional Asset Management’s Medifast MED Stock Holding History

Robeco Institutional Asset Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,250
Closed -$286K – 903
2025
Q1 		$286K Hold
21,250
– – ﹤0.01% 870
2024
Q4 		$374K Hold
21,250
– – ﹤0.01% 849
2024
Q3 		$407K Sell
21,250
-8,104
-28% -$156K ﹤0.01% 851
2024
Q2 		$641K Sell
29,354
-16,122
-35% -$430K ﹤0.01% 817
2024
Q1 		$1.74M Sell
45,476
-50
-0.1% -$2.42K ﹤0.01% 709
2023
Q4 		$3.06M Buy
45,526
+10,646
+31% +$742K 0.01% 636
2023
Q3 		$2.61M Buy
34,880
+12,230
+54% +$1.09M 0.01% 646
2023
Q2 		$2.09M Buy
22,650
+7,801
+53% +$695K 0.01% 691
2023
Q1 		$1.54M Buy
+14,849
New +$1.65M ﹤0.01% 718
2022
Q4 		– Sell
-944
Closed -$102K – 1007
2022
Q3 		$102K Sell
944
-241
-20% -$34.5K ﹤0.01% 882
2022
Q2 		$215K Sell
1,185
-2,224
-65% -$398K ﹤0.01% 825
2022
Q1 		$582K Sell
3,409
-5,039
-60% -$950K ﹤0.01% 758
2021
Q4 		$1.77M Hold
8,448
– – ﹤0.01% 649
2021
Q3 		$1.63M Sell
8,448
-6,833
-45% -$1.68M ﹤0.01% 676
2021
Q2 		$4.33M Sell
15,281
-409
-3% -$111K 0.01% 599
2021
Q1 		$3.32M Sell
15,690
-4,069
-21% -$974K 0.01% 603
2020
Q4 		$3.88M Sell
19,759
-9,910
-33% -$1.75M 0.01% 587
2020
Q3 		$4.88M Sell
29,669
-16,876
-36% -$2.78M 0.02% 520
2020
Q2 		$6.46M Buy
46,545
+8,248
+22% +$757K 0.02% 487
2020
Q1 		$2.4M Buy
38,297
+35,840
+1,459% +$3.26M 0.01% 659
2019
Q4 		$269K Sell
2,457
-25
-1% -$2.42K ﹤0.01% 880
2019
Q3 		$257K Sell
2,482
-1,240
-33% -$133K ﹤0.01% 880
2019
Q2 		$478K Sell
3,722
-41,017
-92% -$5.7M ﹤0.01% 846
2019
Q1 		$5.71M Hold
44,739
– – 0.02% 564
2018
Q4 		$5.59M Buy
44,739
+7,229
+19% +$1.24M 0.03% 514
2018
Q3 		$8.31M Buy
37,510
+34,979
+1,382% +$7.09M 0.03% 478
2018
Q2 		$405K Hold
2,531
– – ﹤0.01% 832
2018
Q1 		$237K Buy
+2,531
New +$189K ﹤0.01% 884

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Robeco Institutional Asset Management's MED Position: Q2 2025 in Review

Robeco Institutional Asset Management sold out of Medifast (MED) in Q2 2025, closing a stake of 21,250 shares — an estimated $286K sold.

Robeco Institutional Asset Management first reported a position in MED in Q1 2018 and held it in 28 quarters. The position peaked at $8.31M in Q3 2018. 120 funds tracked by Wall St. Rank hold MED as of Q2 2025.

  • Robeco Institutional Asset Management reported no remaining Medifast position as of Q2 2025 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 21,250 Medifast shares in Q2 2025, an estimated $286K.
  • Robeco Institutional Asset Management first reported a position in Medifast in Q1 2018 and held it in 28 quarters.
  • Robeco Institutional Asset Management's Medifast position peaked at $8.31M in Q3 2018.
  • 120 funds tracked by Wall St. Rank held Medifast as of Q2 2025.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2025, filed 18 Jul 2025.